Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436992 · ClinicalTrials.gov registry record · NA
Estrogen and Diabetes
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT03436992 is a NA study that has completed, run by Augusta University. The registered enrollment target is 143 participants.
The verdict
NCT03436992, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
Diabetes has recently been referred to as "the epidemic of the 21st century". The reason why women with type 1 diabetes have a 2-3 fold greater risk of cardiovascular disease (CVD) compared to men with type 1 diabetes is unknown.The purpose of this study is to investigate whether or not estrogen contributes to vascular dysfunction in premenopausal women with diabetes.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Resveratrol
- DIETARY_SUPPLEMENT Antioxidant Cocktail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436992
The ClinicalTrials.gov registry entry for NCT03436992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03436992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03436992 about?
NCT03436992 is a clinical study titled "Estrogen and Diabetes". Diabetes has recently been referred to as "the epidemic of the 21st century". The reason why women with type 1 diabetes have a 2-3 fold greater risk of cardiovascular disease (CVD) compared to men with type 1 diabetes is unknown.The purpose of this study is to investigate whether or not estrogen con...
What is the current status of trial NCT03436992?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2018-04-17. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03436992?
The interventions under investigation include: Placebo (OTHER), Resveratrol (DIETARY_SUPPLEMENT), Antioxidant Cocktail (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03436992?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.